These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29925318)

  • 1. Modelling attrition and nonparticipation in a longitudinal study of prostate cancer.
    Spiers S; Oral E; Fontham ETH; Peters ES; Mohler JL; Bensen JT; Brennan CS
    BMC Med Res Methodol; 2018 Jun; 18(1):60. PubMed ID: 29925318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editor's Choice: Deliberative and non-deliberative effects of descriptive and injunctive norms on cancer screening behaviors among African Americans.
    Manning M; Lucas T; Davis SN; Valdimarsdottir HB; Thompson H
    Psychol Health; 2020 Jul; 35(7):774-794. PubMed ID: 31747816
    [No Abstract]   [Full Text] [Related]  

  • 3. Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study.
    Su LJ; Arab L; Steck SE; Fontham ET; Schroeder JC; Bensen JT; Mohler JL
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):844-53. PubMed ID: 21467239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AUDIT-C and ICD codes as phenotypes for harmful alcohol use: association with ADH1B polymorphisms in two US populations.
    Justice AC; Smith RV; Tate JP; McGinnis K; Xu K; Becker WC; Lee KY; Lynch K; Sun N; Concato J; Fiellin DA; Zhao H; Gelernter J; Kranzler HR;
    Addiction; 2018 Dec; 113(12):2214-2224. PubMed ID: 29972609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
    Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
    J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.
    Steck SE; Arab L; Zhang H; Bensen JT; Fontham ET; Johnson CS; Mohler JL; Smith GJ; Su JL; Trump DL; Woloszynska-Read A
    PLoS One; 2015; 10(4):e0125151. PubMed ID: 25919866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
    Hoffman RM; Gilliland FD; Eley JW; Harlan LC; Stephenson RA; Stanford JL; Albertson PC; Hamilton AS; Hunt WC; Potosky AL
    J Natl Cancer Inst; 2001 Mar; 93(5):388-95. PubMed ID: 11238701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and competing risks for mortality in men with prostate cancer.
    Daskivich TJ; Chamie K; Kwan L; Labo J; Dash A; Greenfield S; Litwin MS
    Cancer; 2011 Oct; 117(20):4642-50. PubMed ID: 21480201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.
    Khan S; Cai J; Nielsen ME; Troester MA; Mohler JL; Fontham ET; Hendrix LH; Farnan L; Olshan AF; Bensen JT
    Cancer Causes Control; 2016 Dec; 27(12):1475-1485. PubMed ID: 27830399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are substance use, abuse and dependence associated with study participation? Predictors of offspring nonparticipation in a twin-family study.
    Scherrer JF; Waterman BM; Heath AC; Bucholz KK; True WR; Jacob T
    J Stud Alcohol; 2004 Jan; 65(1):140-4. PubMed ID: 15000514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in survival after diagnosis of prostate cancer in Kentucky, 2001-2010.
    Antwi S; Tucker TC; Coker AL; Fleming ST
    Am J Mens Health; 2013 Jul; 7(4):306-16. PubMed ID: 23339130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
    Mahase SS; D'Angelo D; Kang J; Hu JC; Barbieri CE; Nagar H
    JAMA Netw Open; 2020 Feb; 3(2):e1920471. PubMed ID: 32022878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention and attrition among African Americans in the STAR*D study: what causes research volunteers to stay or stray?
    Murphy EJ; Kassem L; Chemerinski A; Rush AJ; Laje G; McMahon FJ
    Depress Anxiety; 2013 Nov; 30(11):1137-44. PubMed ID: 23723044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
    Defever K; Platz EA; Lopez DS; Mondul AM
    Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Associations of SLCO Transporters with Prostate Cancer Aggressiveness between African Americans and European Americans.
    Tang L; Zhu Q; Wang Z; Shanahan CM; Bensen JT; Fontham ETH; Smith GJ; Pop EA; Azabdaftari G; Mohler JL; Wu Y
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):990-999. PubMed ID: 33619025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
    JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina Health Access and Prostate Cancer Treatment Project (HCaP-NC).
    Morris BB; Farnan L; Song L; Addington EL; Chen RC; Nielsen ME; Mishel M; Mohler JL; Bensen JT
    Cancer; 2015 Jun; 121(12):2029-35. PubMed ID: 25740564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.